KLK3 and posterior cortical atrophy: It is noteworthy to mention that our study was conducted within an organized PCa screening trial and the observed reduction in PSA levels in the statin population could potentially impede the early diagnosis of PCa both in such a program and in real‐world settings where opportunistic screening is prevailing.